Leading Mass Spectrometry Educational Web Site

 

IonSource Daily Links to 
Mass Spectrometry, Biotechnology and Pharmaceutical  Industry News

 

IonSource Home | Disclaimer

Note: News stories may be minutes or several days old and should not be used for investment purposes.

-

-

-
04/21/11 Pfizer Comments on ORAL Sync Tofacitinib Data in EULAR Abstract LB0005
   
  FDA Grants Orphan Drug Designation for Nektar's Investigational Drug, NKTR-102, for Treatment of Women with Ovarian Cancer
   
  Merck and Sanofi Pasteur Initiate Phase III Study in the United States of Pediatric Combination Vaccine to Help Prevent Six Infectious Diseases
   
04/20/11
  Pfizer and Shanghai Pharmaceutical Sign Memorandum of Understanding for Potential Strategic Partnership
   
  Gilead and MicroDose Therapeutx Announce License and Collaboration Agreement to Develop MDT-637 for Treatment of Respiratory Syncytial Virus
   
  Amgen's First Quarter 2011 Revenue Increased 3 Percent to $3.7 Billion
   
  Abbott Reports 17.4 Percent Sales Growth and 12.3 Percent Ongoing Earnings-Per-Share Growth in First Quarter
   
04/19/11 Sangamo BioSciences Announces First Quarter 2011 Conference Call and Webcast
 
 
   
  Genentech: FDA Approves Rituxan Plus a Steroid for Use in Severe Forms of Vasculitis
 
   
  Biogen_Idec FDA Approves Rituxan Plus a Steroid for Use in Severe Forms of Vasculitis
   
  Biogen Idec Receives Positive Opinion from the CHMP and Authorisation from Health Canada on AVONEX PEN
   
04/18/11
 
   
  Lilly Declares Second-Quarter 2011 Dividend
   
04/15/11 Lilly Receives Complete Response Letter From FDA for Liprotamase for the Treatment of Exocrine Pancreatic Insufficiency
 
  Genentech: FDA Approves ACTEMRA® (tocilizumab) for the Treatment of Systemic Juvenile Idiopathic Arthritis (SJIA)
   
  Regulatory Update: GlaxoSmithKline submits additional information for candidate meningococcal and Hib combination vaccine
   
  Merck Commences Tender Offer for all Outstanding Shares of Inspire Pharmaceuticals, Inc.
   
  Roche gains positive CHMP opinion for the combination of Avastin with Xeloda as a first-line treatment for metastatic breast cancer in Europe
   
  Pfizer Announces Top-Line Results Of Third Phase 3 Clinical Trial Of Tofacitinib (CP-690,550) In Patients With Active Rheumatoid Arthritis
   
  AstraZeneca Initiates Phase III Clinical Programme Evaluating NKTR-118 for Treatment of Opioid-Induced Constipation
   
  Merck Commences Tender Offer for all Outstanding Shares of Inspire Pharmaceuticals, Inc.
   
04/13/11 Life Technologies Announces an Automated Sample Preparation System for its Ion PGM™ Sequencer
print
   
04/12/11 Novartis drug Afinitor® recommended by FDA oncology advisory committee for approval to treat advanced NET of pancreatic origin
   
  Bruker Announces Two Major Orders for Novel High-Field 395 GHz Solid State DNP-NMR Systems in Canada and Germany
 
   
04/11/11 Pfizer and Medivation Announce Results from Phase 3 HORIZON Trial of Dimebon in Huntington Disease
   
  Novartis discontinues clinical trial of Tasigna® for investigational use in newly diagnosed patients with unresectable and/or metastatic GIST
   
  Novartis discontinues clinical trial of Tasigna® for investigational use in newly diagnosed patients with unresectable and/or metastatic GIST
   
  Novartis discontinues clinical trial of Tasigna® for investigational use in newly diagnosed patients with unresectable and/or metastatic GIST
   
  FDA Approves Merck's SYLATRON™ (peginterferon alfa-2b) for Injection, a New Adjuvant Treatment for Melanoma with Microscopic or Gross Nodal Involvemen

 
  Novartis therapy GilenyaTM reduced the risk of MS disability progression regardless of treatment history or disease severity, new analysis shows

 
  Biogen Idec Announces Positive Top-Line Results from the First Phase 3 Trial Investigating Oral BG-12 (DIMETHYL FUMARATE) in Multiple Sclerosis
 
   
04/08/11 Sangamo Announces Pricing of Public Offering of Common Stock
   
04/07/11 Sangamo Announces Public Offering of Common Stock
   
  Roche announces positive Phase II results for trastuzumab emtansine (T-DM1) in HER2-positive metastatic breast cancer
   
  Novartis sells global rights to Elidel®, a medicine to treat atopic dermatitis
   
04/06/11 U.S. Prescribing Information for GARDASIL® Updated; Indication Not Granted for Use in Adult Women
   
  GlaxoSmithKline and XenoPort receive FDA approval for Horizant™RLS
   
04/05/11 Merck to Acquire Inspire Pharmaceuticals, Inc.
   
  Incyte Achieves $15 Million Milestone for c-MET Inhibitor Oncology Program
   
04/04/11 Thermo Fisher Scientific Extends Cash Tender Offer for Dionex Corporation
   
  Two Novel Lilly Molecules Target Genetic Mutations That Can Lead to Cancer
   
  Vermillion and Quest Diagnostics Sign Agreement to Make OVA1(R) Available in India
   
  Depomed Appoints James A. Schoeneck President and CEO
   
  Bruker Announces Closing of Michrom Acquisition
   
03/31/11 Biogen Idec and Knopp Biosciences Announce Enrollment of the First Patient in a Global Phase III Study of Dexpramipexole for ALS
   
03/30/11 GlaxoSmithKline confirms Pronova BioPharma reaches agreement with Apotex regarding Lovaza™ US patent litigation
   
  Yale and Gilead Sciences Announce Cancer Research Collaboration
   
03/29/11
   
  Lilly: Effient® Added to Updated ACCF/AHA Clinical Guidelines for ACS-PCI Patients with Unstable Angina and Non-ST Segment Myocardial Infarction
   
  Bayer MaterialScience plans new production facility for coating raw materials in Shanghai
   
  Agilent Technologies and National University of Singapore Sign Research Collaboration Agreement for Lipidomics Research
   
  FDA Clears Abbott’s i-STAT® 1 Wireless Point of Care Testing System
   
03/28/11 Abbott Introduces Micro-Implantation Cataract Suite
   
03/25/11 FDA Expands Indication for ZOSTAVAX®, Merck's Shingles Vaccine,to Include Adults Ages 50 to 59
   
  BMS: FDA Approves YERVOY™ (ipilimumab) for the Treatment of Patients with Newly Diagnosed or Previously-Treated Unresectable or Metastatic Melanoma, the Deadliest Form of Skin Cancer
   
  Second Lucentis Phase III Study Meets Primary Endpoint for Improved Vision in Patients with Diabetic Macular Edema (DME)
   
03/24/11 Portola Pharmaceuticals to Regain Global Rights for Investigational Medicine Betrixaban from Merck
   
  Agilent Technologies Expands Life Sciences and Chemical Analysis Center of Excellence in India
   
03/23/11 FDA informs Novartis of extension to US regulatory review period for QAB149, a novel once-daily bronchodilator for treatment of COPD
   
  Nordion announces Phase III clinical trial to evaluate TheraSphere(R) for liver metastases in colorectal cancer patients
   
  Nordion announces Phase III clinical trial to evaluate TheraSphere(R) in treatment of unresectable hepatocellular carcinoma
   
 
   
  Gilead Prices $1 Billion of Senior Unsecured Notes
   
  Phase III Clinical Trial of Gilead's Investigational Elvitegravir Meets 48-Week Primary Objective
   
  Bayer CropScience to acquire US-based Hornbeck Seed Company. Expansion and investment in southern US soybean seed market
   
  Amgen: Prolia(R) (denosumab) Open-Label Extension Trial Showed Continued Increase in Bone Mineral Density Over Five Years of Treatment With Similar Safety Profile Observed in Pivotal Trial
   
03/22/11
   
03/21/11
   
  BMS Phase III Study of Investigational Compound Ipilimumab Achieves Primary Endpoint of Improvement in Overall Survival in Previously-Untreated Patients with Metastatic Melanoma
   
03/20/11 Genentech Announces Positive Pivotal Phase II Results for Hedgehog Pathway Inhibitor in Advanced Basal Cell Carcinoma
   
03/16/11 Bayer MaterialScience strengthens position in carbon nanotubes
License agreement with U.S.-based company Hyperion concluded
   
03/15/11 Second Phase III study of Novartis JAK inhibitor INC424 meets primary endpoint in patients with myelofibrosis
   
  Incyte's Ruxolitinib (INCB18424) Meets Primary Endpoint in Second Phase III Study
   
  Bruker Announces Launch of High Performance GC CARE Gas Chromatography Column Product Line to Complement Laboratory GC Instruments Business
   
03/14/11 Thermo Fisher Scientific Extends Legacy of Innovation at Pittcon 2011
   
 
   
  Amgen Donates $1 Million to Help Japanese Disaster Victims
   
03/11/11 Gilead Recommends Rejection of Mini-Tender Offer By TRC Capital Corporation
   
03/08/11 BMS: FDA Accepts New Drug Application for Investigational Compound Dapagliflozin for the Treatment of Type 2 Diabetes
   
03/07/11 Proteome Software today released Scaffold PTM
   
03/04/11 U.S. FDA Removes Warning about Potential Liver Injury from Boxed Warning of Prescribing Information for Gilead's Letairis
   
  Bayer extends support to fight Chagas disease
 
  Amgen Completes Acquisition of BioVex
   
03/03/11 Caliper's Microfluidic Technologies Enable 510(k) Approved Multiplexed Immunoassay System for Liver Cancer Risk Assessment
   
03/02/11 Roche: European Commission continues to support Avastin in combination with paclitaxel as an effective treatment option for women with metastatic breast cancer
   
03/01/11 Myriad Announces New $100 Million Share Repurchase Program
   
  Thermo Fisher Scientific Accelerates Expansion in China
   
  ESI Source Solutions: A recent study using the Power Relay to control ABIRD demonstrated an 18% increase in proteins identified with ABIRD!
   
02/28/11
   
02/24/11 FDA Grants Genentech a Hearing on Avastin's Use for Metastatic Breast Cancer in the United States
   
  Bruker Announces Agreement to Acquire Michrom, a Provider of Nanoflow UHPLC Systems and CaptiveSpray Sources for Proteomics
   
  Thermo Fisher Scientific Signs Agreements to Sell Athena Diagnostics and Lancaster Laboratories Businesses for a Total of $940 Million
   
  FDA Grants Genentech a Hearing on Avastin's Use for Metastatic Breast Cancer in the United States
   
  Agilent's NMR Spectrometer Chosen by Harvard Medical School Laboratory for Biomolecular Applications
   
02/22/11 Gilead Sciences to Acquire Calistoga Pharmaceuticals for $375 Million
   
02/21/11 Nordion Signs Share Purchase Agreement to Divest MDS Nordion S.A.
   
02/18/11 Novartis gains positive CHMP opinion for Rasilamlo(TM), a single-pill combination of aliskiren and amlodipine to treat high blood pressure
   
02/17/11 BMS ABILIFY® (aripiprazole) Approved for Maintenance Treatment of Bipolar I Disorder as an Adjunct to Either Lithium or Valproate
   
02/15/11 Thermo Fisher Scientific Extends Cash Tender Offer for Dionex Corporation
   
02/14/11 Thermo Fisher Scientific Prices Offering of Senior Notes
   
02/11/11 First African country introduces GSK’s pneumococcal vaccine through innovative financing mechanism
   
  Genentech: Lucentis Phase III Study Meets Primary Endpoint For Improving Vision In Patients With Diabetic Macular Edema (DME)
   
02/09/11 Myriad's PROLARIS(TM) Test Shown to Significantly Predict Prostate Cancer Outcome
   
02/08/11 Third phase III study of Avastin-based regimen met primary endpoint in ovarian cancer
   
02/07/11 Abbott Introduces Biothreat Assay for PLEX-ID™ System
   
  Bruker Launches pTD(TM), a Compact, Lab Chip-based, Fully Automated and Fast Toxin ID System for Homeland Security
   
02/02/11 Lilly, Bristol-Myers Squibb Stop Enrollment in One of Two Phase III Lung Cancer Trials of Necitumumab
   
01/31/11 FDA approves the Novartis quadrivalent meningococcal conjugate vaccine, Menveo®, for use in children from 2 years of age
   
01/24/11 Thermo Fisher Scientific Notifies Holders of 3.25 Percent Convertible Notes of Option to Require the Company to Purchase Notes
   
  Novartis gains approval for Gilenya® as a first-line disease modifying oral therapy for multiple sclerosis in Switzerland and Australia
   
  GlaxoSmithKline announces start of two phase III studies in advanced/metastatic melanoma
   
  Amgen to Acquire BioVex, a Privately Held Biotechnology Company Headquartered in Woburn, Mass
   
01/21/11 Biogen Idec Receives Negative Opinion from the CHMP on FAMPYRA
   
01/19/11 Roche personalized investigational medicine shows survival benefit in advanced skin cancer
   
01/18/11 Genentech Personalized Investigational Medicine Shows Survival Benefit in Advanced Skin Cancer
   
  Boehringer Ingelheim to Purchase Amgen's Fremont (California) Facility
   
01/14/11 Thermo Fisher Scientific Extends Cash Tender Offer for Dionex Corporation
   
01/03/11 Celera Files U.S. Regulatory Application for KIF6 Genotyping Assay
   
01/02/11
   
12/27/10 Thermo Fisher Scientific Completes Acquisition of Lomb Scientific
   
12/23/10
   
  US FDA Approves New Indication for Merck's HPV Vaccine, GARDASIL®
   
12/22/10 Gilead Terminates Phase III Clinical Trial of Ambrisentan in Patients with Idiopathic Pulmonary Fibrosis
   
  Amylin and Lilly Seek Expanded Use of BYETTA® Along with Basal Insulin
   
12/20/10 Gilead Sciences to Acquire Arresto Biosciences for $225 Million
   
12/16/10 Genentech Provides Update on Avastin for Metastatic Breast Cancer Following Reviews in Europe and the United States
   
12/13/10 John Fenn Dead at 93
   
  Thermo Fisher Scientific to Acquire Dionex Corporation
   
  Roche announces change in Board of Directors
   
  GSK to strengthen Nutritional Healthcare business with acquisition of Maxinutrition
   
  Bruker Receives Order from the University of Utrecht for a Novel 527 GHz Solid State DNP-NMR System for Research on Membrane Proteins and Protein Complexes
   
  Bayer CropScience and Evogene Sign Collaboration Agreement to Improve Wheat Seed
   
12/12/10 Geron Corporation Announces Closing of its Public Offering of Common Stock
   
12/09/10 Study of Novartis drug Zometa for potential new use in early breast cancer did not meet primary endpoint in overall study population
   
  Caliper Life Sciences to Acquire Cambridge Research & Instrumentation
   
  Life Technologies Prices Offering of Senior Notes
   
12/08/10 Myriad Acquires Novel Technology From Melanoma Diagnostics
   
12/07/10 GSK signs agreement to acquire Nanjing MeiRui Pharmaceuticals in China
   
  Geron Corporation Announces the Pricing of Its Public Offering of Common Stock
   
  Merck Prices $2.0 Billion Debt Offering
   
12/06/10 Novartis: Longer-term Phase III data show Novartis drug Tasigna® continues to surpass Glivec® in slowing disease progression in patients with newly diagnosed CML
   
12/05/10 Roche: Phase III study showed Rituxan/MabThera for initial use followed by continued use delayed need for additional therapy in people with asymptomatic follicular lymphoma, a common type of blood cancer
   
  Amgen's Nplate(R) Maintains Platelet Counts for More Than Five Years in Adults With Chronic ITP
   
12/02/10 Merck to Acquire SmartCells, Inc.
   
11/30/10 Thermo Fisher Scientific Signs Definitive Agreement to Acquire Lomb Scientific
   
11/29/10 Government patent box proposals ‘transform’ UK attractiveness for investment
   
  Life Technologies Launches Next-Generation DNA and RNA Quantitation System
   
  GlaxoSmithKline to increase its shareholding in Theravance
   
  Agilent Technologies Awarded $1.8 Million Contract by U.S. Navy for Handheld Spectrum Analyzers
   
11/26/10 GlaxoSmithKline and JSC Binnopharm enter vaccine production alliance in Russia
   
11/23/10 Roche obtains license for EGFR lung cancer assays and will develop Tarceva companion diagnostic test
   
  Lilly and Acrux Receive FDA Approval for Axiron® (Testosterone) Topical Solution CIII
   
11/22/10 Abbott Announces Positive Results from Phase 2 Study of Low Dose Atrasentan for Treatment of Diabetic Kidney Disease
   
11/21/10

Feds OK 2nd human study of embryonic stem cells   SFGate

   
11/18/10 FDA Approves Amgen's XGEVA(TM) (Denosumab) for the Prevention of Skeletal-Related Events in Patients with Bone Metastases from Solid Tumors
   
11/17/10 GSK: Human Genome Sciences and GlaxoSmithKline announce vote of FDA advisory committee to recommend approval of Benlysta® for systemic lupus erythematosus
   
11/11/10 Life Technologies Launches EZValidation(TM) Online Tool for Clinical Laboratory Market
   
11/11/10 Abbott Awards Scholarships to Students Living with Cystic Fibrosis to Help Them Pursue Their Dreams
   
  Geron Announces Two Publications Demonstrating That Its Telomerase Inhibitor Drug Targets Cancer Stem Cells
   
11/10/10 Incyte's Selective Oral JAK1 and JAK2 Inhibitor Demonstrates Positive Phase IIa Results in Patients with Active Rheumatoid Arthritis
   
11/02/10 Bayer: New molecules for efficient insect control: Bayer CropScience, SentiSearch and leading US Universities enter research cooperation  » more
   
  Incyte Achieves $50 Million in Milestones for Initiation of a Joint Global Phase III Clinical Trial of Novel JAK1 and JAK2 Inhibitor INCB18424 in Patients with Polycythemia Vera
   
  Geron Awarded Grants Under Qualifying Therapeutic Discovery Project Program
   
10/30/10 Novartis drug Afinitor® approved by FDA as first medication for children and adults with a benign brain tumor associated with tuberous sclerosis
   
10/29/10 GlaxoSmithKline receives approval in Japan for two medicines: Revolade and Xyzal
   
10/26/10 GSK completes previously reported settlement with U.S. Department of Justice regarding former manufacturing plant
   
  MDS Inc. Completes Name Change to Nordion Inc., and Corresponding Change to Stock Ticker Symbols
   
10/20/10 FDA Approves Herceptin For HER2-Positive Metastatic Stomach Cancer
   
09/29/10 BBGes and GeneBio develop accurate mass LC-MSMS spectra library of drugs with SmileMS
   
09/15/10 Novartis JAK inhibitor provides marked and durable clinical benefits in patients with myelofibrosis, a rare, life-threatening blood cancer
   
09/13/10 Geron Obtains Exclusive License for Deriving Cartilage from Human Embryonic Stem Cells from University of Edinburgh
   
09/09/10 Thermo Fisher Scientific Announces Common Stock Buyback
   
09/07/10 Bristol-Myers Squibb to Acquire ZymoGenetics
   
  University of Maryland School of Medicine Orders a Bruker 950 MHz NMR System for Advanced Molecular Medicine and Structural Biology Research
   
  Bruker Announces 900 MHz NMR Systems Order from the National Institute of Standards and Technology (NIST) for Molecular Structure and Dynamics Research
   
09/03/10 Novartis and collaborators discover novel antimalarial drug candidate
   
08/18/10 Wall Street Journal: The Avastin mugging
   
08/11/10 Amgen Announces Top-Line Results of Phase 3 Head and Neck Cancer Trial
   
07/30/10 Geron to Proceed with First Human Clinical Trial of Embryonic Stem Cell-Based Therapy
   
07/28/10 Abbott Fund-Sponsored Laboratory Training Initiative Helps Stem Critical Shortage of Medical Professionals in California
   
07/23/10 Sandoz leads the way with first generic version of 'gold standard' anti-thrombotic Lovenox®[1]
   
07/20/10 Genentech Provides Update From Avastin FDA Advisory Committee Meeting
   
   
   
   
   
   

Company News

On-Line Magazines Hot News Sites
         
Abbott
Agilent
Amgen
Applied Bio.
Bayer
Biogen
_Idec
BioMarin
Bruker

BMS Company
Caliper
DepoMed
Vermillion
Novartis Diag.
Compugen
Eli Lilly
Genentech
Geron

Gilead
GSK
Incyte Gen.
Life Technologies
Leap Tech.
Nordion
Maxygen


Merck
Millennium
Myriad
Nektar
Novartis
Pfizer
Roche
Sangamo
Shimadzu
Telik
ThermoElectron
LCGC Magazine
Drug Discovery and Development Magazine
New Scientist

Proteomic Company News Links
Check out the Proteomics page at IonSource 

BioWire2K
Coranate
FierceBiotech
GenomeWeb
GE News of the Day
Moreover
ScienceNews On-Line
The Seattle Times
SF Gate Technology News

 

Archive of old news 

home | disclaimer
Copyright © 2001-2014  IonSource, LLC  All rights reserved. 
Last updated:  Wednesday, April 23, 2014 09:25:22 AM

Hit Counter